Literature DB >> 25734697

Using a call center to encourage linkage to care following mobile HIV counseling and testing.

Michiel Adriaan van Zyl1, Leslie Lauren Brown, Kathryn Pahl.   

Abstract

Engaging newly diagnosed HIV+ individuals in treatment is a significant global challenge. As South Africa expands HIV counseling and testing (HCT) services, the growing numbers of people diagnosed with HIV will need innovative links to care approaches in order for treatment to be most effective. While definitions vary, we have defined "linkage to care" as connecting an HIV+ individual to medical care, so that CD4 cell test results are obtained and antiretroviral therapy (ART) eligibility assessed. The study is of HIV+ participants (n = 1096), from either Limpopo or Gauteng provinces from a "Links to Care" program. A two-pronged expanded HCT service was used, which included a community outreach approach to address HIV testing and a call center to encourage and track each patient's linkage to care post-HIV diagnosis. The majority of individuals (51%) were linked to care with a mean time to linkage of 31 days (with most individuals linked in less than 14 days). More females (54%) were linked to care than males (47%) and had higher CD4 cell counts than males; females had a mean CD4 cell count of 440, while males took longer to link to care and had a lower mean CD4 cell count of 331. Females of 23 years or younger had the lowest linkage rate of all females. Findings suggest that expanding HCT services to include innovative links to care approaches can improve linkage to care and subsequently impact HIV prevention.

Entities:  

Keywords:  ART; HCT; HIV/AIDS; South Africa; linkage to care

Mesh:

Year:  2015        PMID: 25734697     DOI: 10.1080/09540121.2015.1015483

Source DB:  PubMed          Journal:  AIDS Care        ISSN: 0954-0121


  7 in total

1.  Barriers and Facilitators of Linkage to and Engagement in HIV Care Among HIV-Positive Men Who Have Sex with Men in China: A Qualitative Study.

Authors:  Yu Liu; Chandra Y Osborn; Han-Zhu Qian; Lu Yin; Dong Xiao; Yuhua Ruan; Jane M Simoni; Xiangjun Zhang; Yiming Shao; Sten H Vermund; K Rivet Amico
Journal:  AIDS Patient Care STDS       Date:  2016-01-19       Impact factor: 5.078

2.  Mobile HIV testing in South Africa: maximizing yield through data-guided site selection.

Authors:  T Mabuto; S Holzman; G Kubeka; C J Hoffmann
Journal:  Public Health Action       Date:  2021-09-21

3.  A Systematic Review of Linkage-to-Care and Antiretroviral Initiation Implementation Strategies in Low- and Middle-Income Countries Across Sub-Saharan Africa.

Authors:  Nneoma E Okonkwo; Alexander Blum; Nikita Viswasam; Elizabeth Hahn; Sofia Ryan; Gnilane Turpin; Carrie E Lyons; Stefan Baral; Bhakti Hansoti
Journal:  AIDS Behav       Date:  2022-01-28

Review 4.  Systematic review and meta-analysis of community and facility-based HIV testing to address linkage to care gaps in sub-Saharan Africa.

Authors:  Monisha Sharma; Roger Ying; Gillian Tarr; Ruanne Barnabas
Journal:  Nature       Date:  2015-12-03       Impact factor: 49.962

5.  Challenges in initiating antiretroviral therapy for all HIV-infected people regardless of CD4 cell count.

Authors:  Jean Joel R Bigna; Claudia S Plottel; Sinata Koulla-Shiro
Journal:  Infect Dis Poverty       Date:  2016-09-05       Impact factor: 4.520

6.  The cascade of care following community-based detection of HIV in sub-Saharan Africa - A systematic review with 90-90-90 targets in sight.

Authors:  Kalpana Sabapathy; Bernadette Hensen; Olivia Varsaneux; Sian Floyd; Sarah Fidler; Richard Hayes
Journal:  PLoS One       Date:  2018-07-27       Impact factor: 3.240

7.  Linkage to care of HIV positive clients in a community based HIV counselling and testing programme: A success story of non-governmental organisations in a South African district.

Authors:  Simukai Shamu; Jean Slabbert; Geoffrey Guloba; Dalene Blom; Sikhulile Khupakonke; Nomea Masihleho; Julius Kamera; Suzanne Johnson; Thato Farirai; Nkhensani Nkhwashu
Journal:  PLoS One       Date:  2019-01-22       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.